Localising and automating supply chains will allow companies to mitigate the impact of tariffs and minimise resulting costs.

Following today’s release of DFS’ figures for the 52 weeks ending 29 June 2025; Matt Walton, senior retail analyst at ...

Grenke has become the 40th organisation to join Acquis Lumia, an industry-wide register of asset finance borrowing created to ...

The success of the post-growth model is reliant on transparency, clear and honest communication with customers and supplier collaboration.

Walmart and its banking partner Mastercard have created a new payment system for international money transfers, data ...

Experian (EXPN), Barratt Redrow (BTRW), B&M European Value (BME), GlobalData (DATA), Robert Walters (RWA), Mobico (MCG), ...

"AstraZeneca’s AL amyloidosis drug fails to impress in Phase III" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

According to GlobalData’s Innovation Radar report, “AI Chips – Trends, Market Dynamics and Innovations,” the global AI chip ...

Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with nmHSPC, but only as a combination therapy.

The US Food and Drug Administration (FDA) has cleared Caranx Medical’s TAVIPILOT Soft, an artificial intelligence (AI)-based guide software for use during Transcatheter Aortic Valve Implantation (TAVI ...

Novartis’ Cosentyx (secukinumab) has failed to show any benefit in the Phase III study in adults with newly diagnosed or relapsing giant cell arteritis (GCA). In the GCAptAIN trial (NCT04930094), ...

Despite persistent signs of a slowdown in U.S. economic data, investors are cautiously increasing their exposure to risk assets, with U.S. equities pushing to new highs. Yet, strategists at GlobalData ...